Primary Low-Dose Tacrolimus Immunosuppressive Prophylaxis for High-Risk Kidney Transplant Recipients

Author： Braun F.   Lorf T.   Grupp C.   Schutz E.   Sattler B.   Canelo R.   Muller G.A.   Ringe B.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.30, Iss.4, 1998-06, pp. : 1221-1223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients

By Lacha J.   Smova M.   Noskova L.   Teplan V.   Vtko S.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2273-2274

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

By Braun F.   Schutz E.   Peters B.   Talaulicar R.   Grupp C.   Undre N.   Schafer A.   Armstrong V.W.   Oellerich M.   Ringe B.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Failure of Ganciclovir Prophylaxis of Primary Cytomegalovirus Disease in Immunologic High-Risk Recipients

By Conti D.J.   Isenberg A.   Shen G.K.   Hahn A.   Singh T.P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1314-1315

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients

By Esmeraldo R.M.   Donadi M.O.R.C.   Oliveira M.L.   Ponte C.N.   Pinheiro P.M.A.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3007-3008

Elsevier

Access to resources Recommend Favorite

Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients

By Boucher A.   Masse M.   Lauzon L.   Morin M.   Dandavino R.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1799-1802

Elsevier

Access to resources Recommend Favorite